Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2013-08-08 Regulatory Filings
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 2, 2013. It details the entry into a material definitive agreement related to the separation of a subsidiary (Ruthigen, Inc.) and its intended initial public offering. It also includes a press release announcing financial results for the fiscal quarter ended June 30, 2013. The document is not a full financial report but a current report disclosing significant corporate events and agreements. The presence of a press release with financial results suggests it is an earnings release announcement. The document is lengthy (15,000 characters) and contains substantive information about the agreement and financial results announcement, consistent with a Current Report (8-K) filing. The best fitting category is Regulatory Filings (RNS) because 8-K filings are general regulatory announcements that do not fit into other specific categories like Earnings Release (ER) or Interim Report (IR) unless they are solely earnings announcements. Since this 8-K includes a material definitive agreement and a financial results press release, it is a regulatory filing rather than a pure earnings release or other report type.
2013-08-08 English
CURRENT REPORT ON FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 29, 2013. It includes a letter to stockholders from the CEO, which is to be mailed with the proxy statement and annual report. The document explicitly states it is furnished pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and is not "filed" for purposes of Section 18, indicating it is a current report rather than a full annual report or other detailed financial filing. The content is a disclosure letter and does not contain comprehensive financial statements or detailed financial analysis. The document is relatively short (5305 characters) and serves as a disclosure rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2013-08-05 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2013-07-29 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to the issuance of common stock shares. It includes detailed information about the offering, company background, risk factors, and use of proceeds. The presence of terms like 'Prospectus Supplement', 'Registration No.', and detailed offering terms indicates this is a capital raising document. It is not an earnings release, annual report, or management discussion, but specifically a financing-related filing. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual prospectus supplement, not just an announcement of a report.
2013-06-27 English
FORM 10-K
Annual Report FY 2013
2013-06-25 English
CURRENT REPORT ON FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing financial results for the fiscal quarter and year ended March 31, 2013. The document includes a press release as an exhibit but does not contain detailed financial statements or comprehensive financial analysis itself. The length is 4015 characters, which is relatively short and consistent with a current report rather than a full financial report. The document is primarily an announcement of financial results, not the full earnings release or annual report. Therefore, the best classification is Earnings Release (ER), as it is the initial announcement of quarterly/periodical financial results with key highlights only.
2013-06-13 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.